(acquired by IBM)
|$2.18 to $73.20||3487%|
|$2.35 to $24.08||925%|
|Cellstar||$1.44 to $13.50||837%|
|Iomega||$3.25 to $13.90||328%|
|Nanophase||$3.75 to $16.75||347%|
|Immunomedics||$1.44 to $29.12||1922%|
|Total Renal Care||$3.12 to $26.95||741%|
|Voxware||$ .90 to $10.31||1046%|
|Corvas||$3.00 to $23.25||675%|
|Cytogen||$2.12 to $17.50||725%|
|Verilink||$3.00 to $14.62||387%|
|GeneLabs||$2.31 to $10.72||364%|
WE CLOSED AGENUS AT $2.55 FOR A 52% GAIN!
The late-December Newsletter is now live and featured are a semiconductor materials provider trading at around 95 cents and a small biotech trading at around 40 cents that has collaborations with several pharmaceuticals. Both are CHANNELED STOCKS that worked well before.
THIS MARKET SELL OFF MAY BE NEARING AN END, SOON. THAT MEANS THERE SHOULD BE A LOT OF GOOD BUYS IN OUR CURRENT PORTFOLIO!!
"I cannot thank you enough for your excellent newsletter... I do believe I have found a new hobby (and a well paying one, at that), thanks to you!"
— B.K. (Contractor in Saudi Arabia)